Earnings per share rose 24% to $3.41, compared to Wall Street's consensus estimate of $2.96, according to FactSet. Revenue for the quarter reached $11.67 billion, well above expectations of $10.91 ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...

FTSE Climbs on rate cut hopes amid inflation heat; GSK Soars 7.6%. US trade gap widens.

Quantum computing is shaping up to be the next big investing revolution, and for a very good reason. With the power to solve ...

This summary covers recent health news, including stable pig prices in Germany, investor focus on AstraZeneca's China probe, ...

Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...

Chancellor Rachel Reeves launched a key policy that, to put it lightly, is not working wonders for the British economy.

In a report released today, Emily Field from Barclays maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...

PHARMACEUTICAL giant AstraZeneca has scrapped plans for a £450m (US$559m) upgrade to its vaccine manufacturing facility in ...

In particular, the charges have targeted two lawmakers typically seen as pharma foes: Sens. Bernie Sanders (I-Vt.) and ...